These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Risk of disability pension among young persons on long-term sick leave].
    Author: Gjesdal S, Haug K, Ringdal PR, Vollset SE, Maeland JG.
    Journal: Tidsskr Nor Laegeforen; 2005 Jun 30; 125(13):1801-5. PubMed ID: 16012545.
    Abstract:
    BACKGROUND: In the late 1990s the incidence of new disability pensioners in Norway increased, especially among young people. This study assessed the risk and possible predictors of a transition to disability among long-term sickness absentees below 40. MATERIAL AND METHODS: The study was carried out in a county with 10 % of Norway's population. All new long-term (i.e. more than 8 weeks) sickness absentees below 40 years over a six-month period in 1994 were included and followed up until year-end 1999. Socio-demographic and medical information were used as independent variables in Cox regression analysis with disability as the outcome variable. RESULTS: The five-year risk of disability was 7.9 % (95 % CI 5.8 % - 10.0 %) for men and 10.3 % (95 % CI 8.5 % - 13.1 %) for women. Among young persons on long-term sickness absence with psychiatric diagnoses the rate of disability was 24 % (95 % CI 15 - 33 %) for men and 11 % (95 % CI 6 - 16 %) for women. In musculoskeletal disorders the risk of disability was 5 % (95 % CI 3 - 7 %) for men and 11 % (95 % CI 8 - 14 %) for women. Women had higher rates of disability among all subgroups of musculoskeletal disorders. Regression analysis showed no gender effect. The following variables increased the risk of disability pension: psychiatric diagnosis (only for men), low income (both genders), increasing age (only women) and previous long-term absence (only for men). INTERPRETATION: A moderate risk of disability pension was found among young people on long-term sick leave. Special interventions targeted at men with psychiatric diagnoses and women with musculoskeletal disorders should be considered.
    [Abstract] [Full Text] [Related] [New Search]